Arvinas (ARVN) Receivables - Other (2017 - 2026)
Arvinas (ARVN) recorded quarterly Receivables - Other of $4.6 million in Q1 2026, up 31.43% quarter-over-quarter from $3.5 million in Q4 2025, and down 42.5% on a YoY basis from $8.0 million in Q1 2025.
Arvinas (ARVN) Receivables - Other (2017 - 2026) Analysis & Trends
Arvinas' Receivables - Other history runs 10 years deep, the most recent figure standing at $4.6 million for Q1 2026.
- In Q1 2026, Receivables - Other fell 42.5% year-over-year to $4.6 million; the TTM figure through Mar 2026 stood at $4.6 million (down 42.5% YoY), while the FY2025 annual figure was $3.5 million, down 56.25% from the prior year.
- Receivables - Other was $4.6 million for Q1 2026 at Arvinas, up from $3.5 million in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $12.1 million in Q1 2022 to a low of $3.5 million in Q4 2025.
- Historically, Receivables - Other has averaged $7.3 million across 5 years, with a median of $7.8 million in 2024.
- The sharpest annual moves came in 2022 and 2023: Receivables - Other surged 146.94% in 2022, then sank 61.16% in 2023.
- A 5-year view of Receivables - Other shows it stood at $10.7 million in 2022, then retreated by 12.15% to $9.4 million in 2023, then dropped by 17.02% to $7.8 million in 2024, then plunged by 55.13% to $3.5 million in 2025, then surged by 31.43% to $4.6 million in 2026.
- The last three Receivables - Other figures came in at $4.6 million (Q1 2026), $3.5 million (Q4 2025), and $3.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Arvinas | 492.16 Mn | -122.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.60 Mn |
| Mar 31, 2026 | 4.60 Mn |
| Dec 31, 2025 | 3.50 Mn |
| Dec 31, 2025 | 3.50 Mn |
| Sep 30, 2025 | 3.70 Mn |
| Sep 30, 2025 | 3.70 Mn |
| Jun 30, 2025 | 4.10 Mn |
| Jun 30, 2025 | 4.10 Mn |
| Mar 31, 2025 | 8.00 Mn |
| Mar 31, 2025 | 8.00 Mn |
| Dec 31, 2024 | 7.80 Mn |
| Dec 31, 2024 | 7.80 Mn |
| Sep 30, 2024 | 8.80 Mn |
| Sep 30, 2024 | 8.80 Mn |
| Jun 30, 2024 | 10.00 Mn |
| Jun 30, 2024 | 10.00 Mn |
| Mar 31, 2024 | 9.00 Mn |
| Mar 31, 2024 | 9.00 Mn |
| Dec 31, 2023 | 9.40 Mn |
| Dec 31, 2023 | 9.40 Mn |